Letter to the Editor
Leukemia (2008) 22, 1062–1064; doi:10.1038/sj.leu.2404996; published online 1 November 2007
Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L
M Christopeit1,4, M Schendel2,4, J Föll3, L P Müller1, G Keysser2 and G Behre1
- 1Bone Marrow Transplantation Unit, Department of Internal Medicine IV—Oncology and Hematology, University Hospital Halle, Ernst-Grube-Strasse 40, Halle, Germany
- 2Department of Internal Medicine I—Gastroenterology and Rheumatology—University Hospital Halle, Ernst-Grube-Strasse 40, Halle, Germany
- 3Department of Pediatrics, University Hospital Halle, Ernst-Grube-Strasse 40, Halle, Germany
Correspondence: G Behre, E-mail: gerhard.behre@medizin.uni-halle.de
4Authors contributed equally to this work.
Top of page
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Molecular Therapy Review
Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks
Bone Marrow Transplantation Review
RESEARCH
Leukemia Original Article
Leukemia Letter
Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis
Molecular Therapy Original Article
